Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

LP (“Bain Capital”) to acquire all of the outstanding shares of Surgery Partners not already owned by Bain Capital for a cash consideration of $25.75 per share (the “Bain Capital Proposal”).

Cantor Fitzgerald reaffirmed its Overweight rating on Surgery Partners (NASDAQ:SGRY) with a steady price target of $36.00. The stock, which has shown significant momentum with a 20% return over the ...

Danielle Burkhalter, Chief Human Resources Officer at Surgery Partners, Inc. (NASDAQ:SGRY), recently sold 167 shares of the company's common stock. The shares were sold at an average price of $25.68 ...

Roche was joined in the financing by a long list of venture investors in the round, including the American Cancer Society’s BrightEdge Ventures, ARK Investments, Bain Capital Life Sciences ...

Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...